Efficient screening strategy for lynch syndrome in Japanese endometrial cancer

Tohoku Journal of Experimental Medicine

Volumn 235, Issue 2, 2015, Pages 117-125

  Sugawara, Tae ^a   Sato, Naoki ^a   Shimizu, Dai ^a   Sato, Toshiharu ^a   Makino, Kenichi ^a   Kito, Masahiko ^a   Tamura, Daisuke ^a   Kato, Aya ^a   Terada, Yukihiro ^a  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Clinical criteria; Endometrial cancer; Lynch syndrome; Molecular analysis; Screening strategy

Indexed keywords

MISMATCH REPAIR PROTEIN; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADULT; AGED; ARTICLE; CANCER SCREENING; CELL NUCLEUS; CLINICAL PRACTICE; CONTROLLED STUDY; DNA METHYLATION ASSAY; ENDOMETRIUM CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEALTH CARE COST; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MEDICAL HISTORY; MLH1 GENE; MOLECULAR BIOLOGY; ONSET AGE; PREDICTION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; RETROSPECTIVE STUDY; TUMOR GENE; ASIAN CONTINENTAL ANCESTRY GROUP; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; COMPLICATION; EARLY DIAGNOSIS; ENDOMETRIUM TUMOR; EPIDEMIOLOGY; GENETICS; JAPAN; MISMATCH REPAIR; MUTATION;

AGE OF ONSET; ASIAN CONTINENTAL ANCESTRY GROUP; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; EARLY DETECTION OF CANCER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; JAPAN; MUTATION;

EID: 84923006628     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.235.117     Document Type: Article

References (45)

1. Aarnio, M., Sankila, R., Pukkala, E., Salovaara, R., Aaltonen, L.A., de la Chapelle, A., Peltomäki, P., Mecklin, J.P. and Järvinen. H.J. (1999) Cancer risk in mutation carriers of DNA-mismatchrepair genes. Int. J. Cancer, 81, 214-218.
2. Backes, F.J., Leon, M.E., Ivanov, I., Suarez, A., Frankel, W.L., Hampel, H., Fowler, J.M., Copeland, L.J., O’Malley, D.M. and Cohn, D.E. (2009) Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer. Gynecol. Oncol., 114, 486-490.
3. Backes, F.J., Mitchell, E., Hampel, H. and Cohn, D.E. (2011) Endometrial cancer patients and compliance with genetic counseling: room for improvement. Gynecol. Oncol., 123, 532-536.
4. Batte, B.A., Bruegl, A.S., Daniels, M.S., Ring, K.L., Dempsey, K.M., Djordjevic, B., Luthra, R., Fellman, B.M., Lu, K.H. and Broaddus, R.R. (2014) Consequences of universal MSI/IHC in screening endometrial cancer patients for Lynch syndrome. Gynecol. Oncol., 134, 319-325.
5. Benatti, P., Sassatelli, R., Roncucci, L., Pedroni, M., Fante, R., Di Gregorio, C., Losi, L., Gelmini, R. and Ponz de Leon, M. (1993) Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with “suspected HNPCC.” A population-based study in northern Italy. Colorectal Cancer Study Group. Int. J. Cancer, 54, 371-377.
6. Black, D., Soslow, R.A., Levine, D.A., Tornos, C., Chen, S.C., Hummer, A.J., Bogomolniy, F., Olvera, N., Barakat, R.R. and Boyd, J. (2006) Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma. J. Clin. Oncol., 24, 1745-1753.
7. Boilesen, A.E., Bisgaard, M.L. and Bernstein, I. (2008) Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families. Acta Obstet. Gynecol. Scand., 87, 1129-1135.
8. Bruegl, A.S., Djordjevic, B., Batte, B., Daniels, M., Fellman, B., Urbauer, D., Luthra, R., Sun, C., Lu, K.H. and Broaddus, R.R. (2014a) Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer. Cancer Prev. Res., 7, 686-697.
9. Bruegl, A.S., Djordjevic, B., Urbauer, D.L., Westin, S.N., Soliman, P.T., Lu, K.H., Luthra, R. and Broaddus, R.R. (2014b) Utility of MLH1 methylation analysis in the clinical evaluation of Lynch syndrome in women with endometrial cancer. Curr. Pham. Des., 20, 1655-1663.
10. Buchanan, D.D., Tan, Y.Y., Walsh, M.D., Clendenning, M., Metcalf, A.M., Ferguson, K., Arnold, S.T., Thompson, B.A., Lose, F.A., Parsons, M.T., Walters, R.J., Pearson, S.A., Cummings, M., Oehler, M.K., Blomfield, P.B., et al. (2014) Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. J. Clin. Oncol., 32, 90-100.
11. Esteller, M., Levine, R., Baylin, S.B., Ellenson, L.H. and Herman, J.G. (1998) MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene, 17, 2413-2417.
12. Evaluation of Geonomic Applications in Practice and Prevention (EGAPP) Working Group (2009) Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet. Med., 11, 35-41.
13. Ferguson, S.E., Aronson, M., Pollett, A., Eiriksson, L.R., Oza, A.M., Gallinger, S., Lerner-Ellis, J., Alvandi, Z., Bernardini, M.Q., MacKay, H.J., Mojtahedi, G., Tone, A.A., Massey, C. and Clarke, B.A. (2014) Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing. Cancer, 120, 3932-3939.
14. Garg, K. and Soslow, R.A. (2009) Lynch syndrome (hereditary nonpolyposis colorectal cancer) and endometrial carcinoma. J. Clin. Pathol., 62, 679-684.
15. Gausachs, M., Mur, P., Corral, J., Pineda, M., González, S., Benito, L., Menéndez, M., Espinás, J.A., Brunet, J., Iniesta, M.D., Gruber, S.B., Lázaro, C., Blanco, I. and Capellá, G. (2012) MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study. Eur. J. Hum. Genet., 20, 762-768.
16. Hampel, H., Frankel, W., Panescu, J., Lockman, J., Sotamaa, K., Fix, D., Comeras, I., La Jeunesse, J., Nakagawa, H., Westman, J.A., Prior, T.W., Clendenning, M., Penzone, P., Lombardi, J., Dunn, P., et al. (2006) Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res., 66, 7810-7817.
17. Hendriks, Y.M., Wagner, A., Morreau, H., Menko, F., Stormorken, A., Quehenberger, F., Sandkuijl, L., Moller, P., Genuardi, M., Van Houwelingen, H., Tops, C., Van Puijenbroek, M., Verkuijlen, P., Kenter, G., Van Mil, A., et al. (2004) Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology, 127, 17-25.
18. Hirai, Y., Banno, K., Suzuki, M., Ichikawa, Y., Udagawa, Y., Sugano, K. and Miki, Y. (2008) Molecular epidemiological and mutational analysis of DNA mismatch repair (MMR) genes in endometrial cancer patients with HNPCC-associated familial predisposition to cancer. Cancer Sci., 99, 1715-1719.
19. Kwon, J.S., Scott, J.L., Gilks, C.B., Daniels, M.S., Sun, C.C. and Lu, K.H. (2011) Testing women with endometrial cancer to detect Lynch syndrome. J. Clin. Oncol., 29, 2247-2252.
20. Lancaster, J.M., Powell, C.B., Kauff, N.D., Cass, I., Chen, L.M., Lu, K.H., Mutch, D.G., Berchuck, A., Karlan, B.Y. and Herzog, T.J. (2007) Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol. Oncol., 107, 159-162.
21. Leenen, C.H., van Lier, M.G., van Doorn, H.C., van Leerdam, M.E., Kooi, S.G., de Waard, J., Hoedemaeker, R.F., van den Ouweland, A.M., Hulspas, S.M., Dubbink, H.J., Kuipers, E.J., Wagner, A., Dinjens, W.N. and Steyerberg, E.W. (2012) Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤ 70 years. Gynecol. Oncol., 125, 414-420.
22. Lindor, N.M., Petersen, G.M., Hadley, D.W., Kinney, A.Y., Miesfeldt, S., Lu, K.H., Lynch, P., Burke, W. and Press, N. (2006) Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA, 296, 1507-1517.
23. Lipton, L.R., Johnson, V., Cummings, C., Fisher, S., Risby, P., Eftekhar Sadat, A.T., Cranston, T., Izatt, L., Sasieni, P., Hodgson, S.V., Thomas, H.J. and Tomlinson, I.P. (2004) Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. J. Clin. Oncol., 22, 4934-4943.
24. Lu, K.H. and Broaddus, R.R. (2005) Gynecologic cancers in Lynch syndrome/HNPCC. Fam. Cancer, 4, 249-254.
25. Lu, K.H., Dinh, M., Kohlmann, W., Watson, P., Green, J., Syngal, S., Bandipalliam, P., Chen, L.M., Allen, B., Conrad, P., Terdiman, J., Sun, C., Daniels, M., Burke, T., Gershenson, D.M., et al. (2005) Gynecologic cancer as a “sentinel cancer” for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet. Gynecol., 105, 569-574.
26. Lu, K.H., Schorge, J.O., Rodabaugh, K.J., Daniels, M.S., Sun, C.C., Soliman, P.T., White, K.G., Luthra, R., Gershenson, D.M. and Broaddus, R.R. (2007) Prospective determination of prevalence of Lynch syndrome in young women with endometrial cancer. J. Clin. Oncol., 25, 5158-5164.
27. Matthews, K.S., Estes, J.M., Conner, M.G., Manne, U., Whitworth, J.M., Huh, W.K., Alvarez, R.D., Straughn, J.M. Jr., Barnes, M.N. and Rocconi, R.P. (2008) Lynch syndrome in women less than 50 years of age with endometrial cancer. Obstet. Gynecol., 111, 1161-1166.
28. Modica, I., Soslow, R.A., Black, D., Tornos, C., Kauff, N. and Shia, J. (2007) Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma. Am. J. Surg. Pathol., 31, 744-751.
29. Moline, J., Mahdi, H., Yang, B., Biscotti, C., Roma, A.A., Heald, B., Rose, P.G., Michener, C. and Eng, C. (2013) Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center. Gynecol. Oncol., 130, 121-126.
30. Park, J.G., Park, Y.J., Wijnen, J.T. and Vasen, H.F. (1999) Geneenvironment interaction in hereditary nonpolyposis colorectal cancer with implications for diagnosis and genetic testing. Int. J. Cancer, 82, 516-519.
31. Perez-Carbonell, L., Alenda, C., Paya, A., Castillejo, A., Barbera, V.M., Guillen, C., Rojas, E., Acame, N., Gutierrez-Avino, F.J., Castells, A., Llor, X., Andreu, M., Soto, J.L. and Jover, R. (2010) Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome. J. Mol. Diagn., 12, 498-504.
32. Perez-Carbonell, L., Ruiz-Ponte, C., Guarinos, C., Alenda, C., Paya, A., Brea, A., Egoavil, C.M., Castillejo, A., Barbera, V.M., Bessa, X., Xicola, R.M., Rodriguez-Soler, M., Sanchez-Fortun, C., Acame, N., Castellvi-Bel, S., et al. (2012) Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer. Gut, 61, 865-872.
33. Pinol, V., Castells, A., Andreu, M., Castellvi-Bel, S., Alenda, C., Llor, X., Xicola, RM., Rodriguez-Moranta, F., Paya, A., Jover, R. and Bessa, X. (2005) Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA, 293, 1986-1994.
34. Resnick, K.E., Hampel, H., Fishel, R. and Cohn, D.E. (2009) Current and emerging trends in Lynch syndrome identification in women with endometrial cancer. Gynecol. Oncol., 114, 128-134.
35. Rodriguez-Soler, M., Perez-Carbonell, L., Guarinos, C., Zapater, P., Castillejo, A., Barbera, V.M., Juarez, M., Bessa, X., Xicola, R.M., Clofent, J., Bujanda, L., Balaguer, F., Rene, J.M., de-Castro, L., Marin-Gabriel, J.C., et al. (2013) Risk of cancer in cases of suspected Lynch syndrome without germline mutation. Gastroenterology, 144, 926-932.
36. Ryan, P., Mulligan, A.M., Aronson, M., Ferguson, S.E., Bapat, B., Semotiuk, K., Holter, S., Kwon, J., Kalloger, S.E., Gilks, C.B., Gallinger, S., Pollett, A. and Clarke, B.A. (2012) Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries. Cancer, 118, 681-688.
37. Senter, L., Clendenning, M., Sotamaa, K., Hampel, H., Green, J., Potter, J.D., Lindblom, A., Lagerstedt, K., Thibodeau, S.N., Lindor, N.M., Young, J., Winship, I., Dowty, J.G., White, D.M., Hopper, J.L., et al. (2008) The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology, 135, 419-428.
38. Stoffel, E., Mukherjee, B., Raymond, V.M., Tayob, N., Kastrinos, F., Sparr, J., Wang, F., Bandipalliam, P., Syngal, S. and Gruber, S.B. (2009) Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology, 137, 1621-1627.
39. Syngal, S., Fox, E.A., Eng, C., Kolodner, R.D. and Garber, J.E. (2000) Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J. Med. Genet., 37, 641-645.
40. Tutlewska, K., Lubinski, J. and Kurzawski, G. (2013) Germline deletions in the EPCAM gene as a cause of Lynch syndrome -literature review. Hered. Cancer Clin. Pract., 11, 9.
41. Umar, A., Boland, C.R., Terdiman, J.P., Syngal, S., de la Chapelle, A., Rüschoff, J., Fishel, R., Lindor, N.M., Burgart, L.J., Hamelin, R., Hamilton, S.R., Hiatt, R.A., Jass, J., Lindblom, A., Lynch, H.T., et al. (2004) Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J. Natl. Cancer Inst., 96, 261-268.
42. Vasen, H.F., Blanco, I., Aktan-Collan, K., Gopie, J.P., Alonso, A., Aretz, S., Bernstein, I., Bertario, L., Burn, J., Capella, G., Colas, C., Engel, C., Frayling, I.M., Genuardi, M., Heinimann, K., et al. (2013) Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut, 62, 812-823.
43. Vasen, H.F., Möslein, G., Alonso, A., Bernstein, I., Bertario, L., Blanco, I., Burn, J., Capella, G., Engel, C., Frayling, I., Friedl, W., Hes, F.J., Hodgson, S., Mecklin, J.P., Møller, P., et al. (2007) Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J. Med. Genet., 44, 353-362.
44. Vasen, H.F., Watson, P., Mecklin, J.P. and Lynch, H.T. (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology, 116, 1453-1456.
45. Win, A.K., Lindor, N.M., Winship, I., Tucker, K.M., Buchanan, D.D., Young, J.P., Rosty, C., Leggett, B., Giles, G.G., Goldblatt, J., Macrae, F.A., Parry, S., Kalady, M.F., Baron, J.A., Ahnen, D.J., et al. (2013) Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J. Natl. Cancer Inst., 105, 274-279.